Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | PPARG | P37231 | 6/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 4/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.77 |
| ▸ | F7 | P08709 | 4/20 | 0.77 |
| ▸ | F3 | P13726 | 4/20 | 0.77 |
| ▸ | PPARD | Q03181 | 4/20 | 0.77 |
| ▸ | PPARA | Q07869 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Doconexent SCHEMBL18274946 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL2241832 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185529 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185428 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL288437 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL17289459 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185531 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL13900774 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185505 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| SCHEMBL6473094 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119709889-A | Lipoxygenase catalyzes the production of unsaturated C10-aldehydes from polyunsaturated fatty acids (PUFAs) | 弗门尼舍有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-113286890-B | Lipoxygenase catalyzes the production of unsaturated C10-aldehydes from polyunsaturated fatty acids (PUFAs) | 弗门尼舍有限公司 | 2025-01-17 | — | — | CN | claimed |
| CN-113286890-A | Lipoxygenase catalyzing the production of unsaturated C10-aldehydes from polyunsaturated fatty acids (PUFA) | 弗门尼舍有限公司 | 2021-08-20 | — | — | CN | claimed |
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20190269700-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2019-09-05 | — | — | US | disclosed |
| US-20180104257-A1 | (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use | LIPOCINE INC. (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | disclosed |
| EP-3185873-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | Lipocine Inc. (US) | 2017-07-05 | — | — | EP | disclosed |
| US-20170184964-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9573875-B2 | Procedure for the obtainment of fatty acids of pharmacological and nutritional interest | BRACKENIERS, THIERRY (BE) | 2017-02-21 | — | — | US | disclosed |
| US-9573875-B2 | Procedure for the obtainment of fatty acids of pharmacological and nutritional interest | BRACKENIERS, THIERRY (BE) | 2017-02-21 | — | — | US | disclosed |
| EP-2586869-B1 | PROCESS FOR PRODUCING (POLY)UNSATURATED FATTY ACIDS EMPLOYING MICROALGAE | STROÏAZZO-MOUGIN BERNARD A J (ES) | 2016-11-16 | — | — | EP | disclosed |
| US-20160193225-A1 | (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | disclosed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2016033611-A1 | (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-20130197086-A1 | PROCEDURE FOR THE OBTAINMENT OF FATTY ACIDS OF PHARMACOLOGICAL AND NUTRITIONAL INTEREST | BRACKENIERS, THIERRY (BE) | 2013-08-01 | — | — | US | disclosed |
| US-20130197086-A1 | PROCEDURE FOR THE OBTAINMENT OF FATTY ACIDS OF PHARMACOLOGICAL AND NUTRITIONAL INTEREST | BRACKENIERS, THIERRY (BE) | 2013-08-01 | — | — | US | disclosed |
| WO-2011161274-A1 | PROCEDURE FOR THE OBTAINMENT OF FATTY ACIDS OF PHARMACOLOGICAL AND NUTRITIONAL INTEREST | BIO FUEL SYSTEMS, S.L. (ES) | 2011-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130197086-A1 | PROCEDURE FOR THE OBTAINMENT OF FATTY ACIDS OF PHARMACOLOGICAL AND NUTRITIONAL INTEREST | FASN, SQLE, FADS2 | ALDH1A1 1683/4885PPARG 15/4885CYP19A1 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.